06:18:24 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Ndatalyze Corp
Symbol NDAT
Shares Issued 26,121,425
Close 2022-03-29 C$ 0.25
Market Cap C$ 6,530,356
Recent Sedar Documents

Ndatalyze hires Venture Play for marketing services

2022-03-30 13:26 ET - News Release

Mr. Jim Durward reports

NDATALYZE ENGAGES VENTURE PLAY FOR YMI MARKETING CAMPAIGN

Ndatalyze Corp. has engaged Venture Play to formulate the corporation's marketing strategy and program related to the upcoming launch of the corporation's advanced YMI machine learning mental health diagnostic tool.

Ndatalyze's president Jim Durward states: "We previously engaged Venture Play to conduct a primary market research program and were impressed with the outcome. This new engagement provides for Venture Play to develop a comprehensive marketing program for YMI and we have great confidence that the result will be a progressive program that addresses consumer needs in the face of the ongoing mental health crisis. The engagement is an unrelated, third party, all-cash arrangement -- there are no NDAT shares involved."

The corporation further reports that the YMI application continues to improve its user experience upgrades in response to its continuing beta testing and that the beta testing is expected to become open to the public in the near future. Currently, five of seven mental conditions are operational with the final two conditions expected before the end of April, 2022.

About Ndatalyze Corp.

Ndatalyze generates technology-based, health-related solutions. The YMI division is developing a machine-learning-based, on-line consumer mental health application and the MLdelic division is focusing on applying machine learning to assist in the prediction of potential benefits associated with the use of natural compounds within the mental health sector. Both YMI and MLdelic are based on the corporation's proprietary reference database consisting of over 1,200 biometric records including same-time-of-day EEG (electroencephalogram) data. With installations worldwide, its Medxtractor division manufactures small-scale bio-extractors that are used to extract compounds from a variety of botanical biomasses. While the Medxtractor division is currently generating cash flow, both YMI and MLdelic are in development and, accordingly, the corporation cannot accurately predict if or when these applications will become cash flow generators.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.